We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare... read more Featured Products: More products

Download Mobile App




New Interventional Oncology Research Program Launched

By HospiMedica International staff writers
Posted on 20 Jun 2016
One of the world’s largest international medical imaging companies has entered into a new cancer research program with leading innovators to explore innovative image-guided therapies, and diagnostic imaging and informatics solutions.

The new multi-year program is part of an existing master research agreement with a leading medical school, and is intended to help find ways to improve cancer care using medical imaging for localization and quantification of the disease, therapy planning, and treatment guidance and assessment.

The agreement is between Royal Philips (Amsterdam, the Netherlands) and the Yale School of Medicine (New Haven, CT, USA).

Philips develops and manufactures diagnostic imaging equipment including Computed Tomography (CT), ultrasound, Magnetic Resonance Imaging (MRI) scanners, image-guided therapy solutions, and related health informatics solutions for the acquisition, integration, and analysis of the data.

Prof. More...
Geschwind, chair of Radiology and Biomedical Imaging, Yale School of Medicine, said, "Over the past few years there have been significant developments in image-guided therapy to locally treat tumors, with the result that interventional oncology procedure volumes have grown rapidly. However, the biggest remaining challenge is that it is difficult to predict the effectiveness of the procedure. Together with Philips, we are embarking on a new multi-year research program with the aim to redefine and standardize this type of minimally-invasive treatment to achieve more predictable and better controlled procedure outcomes, and ultimately enhanced patient care.”

Related Links:
Royal Philips
Yale School of Medicine


New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Medical Adhesive
MED 5570U
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.